Please check your internet connection and try again.
# Megacv Duo (Amoxicillin/Clavulanate Potassium)
## Overview
Megacv Duo is a combination antibiotic consisting of amoxicillin (a beta-lactam) and clavulanate potassium (a beta-lactamase inhibitor). The inhibitor expands the spectrum of activity to include beta-lactamase-producing organisms that are otherwise resistant to amoxicillin alone.
## Primary Indications
* Community-acquired pneumonia
* Acute bacterial sinusitis
* Acute otitis media
* Skin and skin structure infections
* Urinary tract infections (UTIs)
* Bite wounds (human or animal)
## Adult Dosing
* **Standard dosing:** 875 mg/125 mg orally every 12 hours.
* **Severe infections:** 875 mg/125 mg orally every 8 hours.
* *Note:* Extended-release tablets (1000 mg/62.5 mg) are typically dosed 2 tablets every 12 hours.
## Pediatric Dosing
* **General infection:** 20–45 mg/kg/day (based on amoxicillin component) divided every 8–12 hours.
* **Acute Otitis Media (High Dose):** 80–90 mg/kg/day (amoxicillin) divided every 12 hours, using a 7:1 or 14:1 formulation to limit clavulanate content and reduce diarrhea.
* *Maximum weight-based dose:* Should not exceed adult maximums.
## Dose Adjustments
* **Renal Impairment:** If CrCl < 30 mL/min, use of extended-release formulations and certain high-strength tablets is not recommended. Dosing frequency must be extended (e.g., every 24 hours) for severe impairment.
* **Hepatic Impairment:** Use with caution; monitor hepatic function periodically.
## Contraindications
* History of amoxicillin/clavulanate-associated cholestatic jaundice or hepatic dysfunction.
* Severe hypersensitivity (anaphylaxis) to any penicillin or beta-lactam.
## Adverse Effects
* **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, abdominal pain, rash (non-allergic maculopapular rash).
* **Serious:** *Clostridioides difficile*-associated diarrhea (CDAD), hepatotoxicity (cholestatic jaundice), severe hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome).
## Key Drug Interactions
* **Methotrexate:** Amoxicillin may decrease renal clearance of methotrexate, increasing toxicity risk.
* **Warfarin:** May increase INR/bleeding risk due to alteration of gut flora (vitamin K synthesis).
* **Allopurinol:** Increased incidence of skin rashes.
* **Oral Contraceptives:** Potential for reduced efficacy (though clinical evidence is inconsistent).
## Monitoring
* Monitor for signs of hypersensitivity/anaphylaxis during initial doses.
* Monitor liver function tests (LFTs) in patients receiving prolonged therapy.
* Assess for frequent diarrhea or signs of colitis.
* Monitor renal function in patients with baseline impairment.
## Clinical Pearls
* **Administration:** Take with food or a meal to improve absorption and minimize gastrointestinal upset.
* **Clavulanate-Limited Toxicity:** Diarrhea is dose-dependent; use the lowest strength of clavulanate that achieves the clinical goal.
* **Allergy Cross-Reactivity:** Use caution in patients with cephalosporin allergies; avoid if the patient has a history of type-1 hypersensitivity (anaphylaxis/hives) to penicillins.
* **Formulation Warning:** Different strengths of fixed-dose combinations are not always interchangeable; verify the specific milligram ratio (e.g., 250/125 vs 500/125 vs 875/125) to avoid over-dosing clavulanate.
***
**Educational Disclaimer:** This information is for educational purposes only. Drug dosing, indications, and safety profiles are subject to change. Always verify current prescribing information, local clinical guidelines, and institutional policies before prescribing or administering any medication.
